Is Summit Therapeutics Inc. stock a buy or sell right now?

Based on current indicators, Summit Therapeutics Inc. shows a Buy signal, supported by strong momentum and a confirmed uptrend.

What is Summit Therapeutics Inc.’s RSI?

RSI is 68.65, showing balanced momentum within the normal range.

What does MACD indicate for SMMT?

MACD at 0.74 signals bullish momentum with buyers in control.

What are Summit Therapeutics Inc.’s key support and resistance levels?

Support sits around $14.02, while resistance is near $19.06. A breakout above $19.06 would open the door for further upside.

Summit Therapeutics Inc.

Get $10 bonus on your first $100 deposit for SMMT

SMMT•NASDAQ

Healthcare

Biotechnology

Get $10 bonus on your first $100 deposit for SMMT

$19.38

$0.46(2.43%)

U.S. Market opens in 27h 56m

Summit Therapeutics Inc. (SMMT) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Summit Therapeutics Inc. (NASDAQ:SMMT).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

SMMT Technical Analysis Summary

Summit Therapeutics Inc. stock currently shows a bullish trend, supported by momentum and strong buying pressure.

Overall Sentiment:Buy

Momentum:Bullish (RSI: 68.65)

Trend Strength:Moderate (ADX: 25.46)

Volatility:High (ATR: 1.04)

Support/Resistance:$14.02 – $19.06 (Bollinger Bands)

Overall, Summit Therapeutics Inc. remains neutral, with indicators showing mixed momentum.

Momentum Indicators

RSI (14): 68.65

Bullish

Above midpoint suggests upward bias.

Stochastic %K: 91.01

Bearish

Overbought levels may trigger pullback.

Williams %R: -10.22

Bearish

Overbought levels may trigger correction.

Rate of Change (ROC): 20.22

Strongly Bullish

Strong upside momentum.

Takeaway:Summit Therapeutics Inc. shows strong bullish momentum, with buyers firmly in control.

Trend & Volatility

MACD: 0.74

Bullish

Bullish, trend momentum is strengthening.

ADX: 25.46

Moderate

Moderate trend, direction gaining strength.

ATR (14): 1.04

Low

Low volatility, stable price action.

CCI (14): 148.17

Bearish Risk

Bearish risk, overbought levels suggest caution.

Takeaway:Summit Therapeutics Inc. shows a firm trend supported by momentum, though one signal suggests caution.

Support & Resistance indicators

Bollinger Bands

Upper Band

$19.06

Middle Band (SMA 20)

$16.54

Lower Band

$14.02

Current Position

Above Upper Band

Takeaway:Summit Therapeutics Inc. trades near the upper band, signaling overbought conditions and risk of pullback.

Keltner Channels

Upper Channel

$19.02

Middle Line (EMA 20)

$16.94

Lower Channel

$14.85

Squeeze Status

No Squeeze

Takeaway:Summit Therapeutics Inc. trades near the upper channel, signaling resistance and risk of pullback.

Volume & Money Flow Analysis

On-Balance Volume-4.08M

Money Flow Index72.20Bullish, inflows support continued momentum.

Relative Vigor Index59.20Neutral to Bullish, buyers hold a slight edge.

Overall Takeaway:SMMT shows bullish money flow, with volume and vigor supporting buyers.

Technical Trading Signals Summary

Based on the current technical analysis of Summit Therapeutics Inc., here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

ADX above 20 → strong underlying trend.

Price trading above middle Bollinger Band → mid-term support intact.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

Price near upper Bollinger Band → potential resistance and pullback risk.

Overall Recommendation:Summit Therapeutics Inc. currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.